Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Tissue-type plasminogen activator (T-PA). Structure and function].

T Pietrucha1, C S Cierniewski

  • 1Zakładu Biofizyki Instytutu Fizjologii i Biochemii Akademii Medycznej, Lodzi.

Acta Haematologica Polonica
|January 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Determination of benzene, toluene and xylene concentration in humid air using differential ion mobility spectrometry and partial least squares regression.

Talanta·2016
Same author

Does reduced membrane lipid fluidity underlie the altered thrombin-induced expression of integrin α(IIb)β(3) and PADGEM-140 in membranes of platelets from diabetic juveniles?

Platelets·2010
Same author

Two polymorphisms of the FVII gene and their impact on the risk of myocardial infarction in poles under 45 years of age.

Molekuliarnaia biologiia·2010
Same author

DNAzymes to mouse beta1 integrin mRNA in vivo: targeting the tumor vasculature and retarding cancer growth.

Cancer gene therapy·2009
Same author

Possible mechanisms of the altered platelet volume distribution in type 2 diabetes: does increased platelet activation contribute to platelet size heterogeneity?

Platelets·2006
Same author

Membrane lipid fluidity of blood platelets: a common denominator that underlies the opposing actions of various agents that affect platelet activation in whole blood.

Platelets·2006
Same journal

[Risk of transmission of blood-derived pathogens by transfusion in Poland].

Acta haematologica Polonica·2020
Same journal

[Emerging infectious diseases in the context of blood safety].

Acta haematologica Polonica·2020
Same journal

<i>Quo Vadis</i> medycyno regeneracyjna?: Quo Vadis Regenerative Medicine?

Acta haematologica Polonica·2013
Same journal

[RHnull syndrome--diagnostic and therapeutic problems].

Acta haematologica Polonica·1996
Same journal

[Unclassified chronic myeloproliferative Ph(-); i(17q); +8 syndrome with mixed myelo-megakaryoblastic crisis--case report].

Acta haematologica Polonica·1996
Same journal

Acute myelofibrosis in children: report on two cases.

Acta haematologica Polonica·1996
See all related articles

This study details 10 years of research on tissue-type plasminogen activator (t-PA), focusing on its structure and function. Findings clarify the properties of one- and two-chain t-PA and its molecular domain structures.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Hematology

Context:

  • Tissue-type plasminogen activator (t-PA) is crucial for fibrinolysis.
  • Understanding t-PA structure-function relationships is key to thrombolytic therapy.
  • Decades of research have elucidated t-PA's role in dissolving blood clots.

Purpose:

  • To consolidate and present 10 years of research findings on t-PA.
  • To characterize the structural properties of one- and two-chain t-PA.
  • To analyze the functional significance of distinct domains within the t-PA molecule.

Summary:

  • Comprehensive review of structure-function studies on tissue-type plasminogen activator (t-PA) over the last decade.
  • Detailed characterization of the distinct properties exhibited by single-chain and double-chain forms of t-PA.

Related Experiment Videos

  • In-depth analysis of the molecular architecture, including the specific roles of individual domains within the t-PA protein.
  • Impact:

    • Provides a foundational resource for researchers in thrombosis and thrombolysis.
    • Enhances understanding of t-PA's mechanism of action in clot dissolution.
    • Informs the development of novel therapeutic strategies targeting the fibrinolytic system.